Jeni Got Her Life Back, Thanks to a Biosimilar | Association for Accessible Medicines
In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19
Jeni, 35, from Santa Clarita, CA takes a biosimilar medicine for her pancolitis.

Jeni Got Her Life Back, Thanks to a Biosimilar

In 2019, Jeni Doerr finally received a diagnosis for her recent illnesses – pancolitis. Doerr, 35, from Newhall, CA, is featured in AAM’s recently released 2020 Generic Drug & Biosimilars Access & Savings in the U.S. report.

Here’s Jeni’s story, in her own words:

“I had been experiencing stomach issues since June 2017. Every time I went to the bathroom, I would lose blood and I couldn’t eat anything. I became anemic and after my symptoms got even worse I finally went to the ER where I received a colonoscopy and was diagnosed with pancolitis. I was then in and out of the hospital a few times trying different name brand biologic medications that didn’t work. I felt like I had lost everything I loved. I couldn’t hike, rock climb or even play with my dog, Sally.

Finally, after I was in the hospital for a full week, I was switched to a biosimilar and within two days I started to feel normal. I went from paying for a biologic that didn’t work well to not paying anything for a biosimilar that truly helped. My last treatment was in early 2020 and since then I have been able to hike, rock climb and take my dog out for walks. If I had known about biosimilars earlier, I would have never tried anything else. Biosimilars truly gave me my life back!”

View Jeni's Story


Related Resources

FDA-approved biosimilars have the potential to provide 1.2 million patients access to treatments for rheumatoid arthritis, Crohn’s disease, cancer and other chronic conditions, at a lower cost. Over the next ten years, biosimilars could save the entire U.S. health care system $54 billion. Find out more about how biosimilars truly benefit everyone in this infographic from AAM's Biosimilars Council.

Originally published on the Biosimilars Council website.


Erica Klinger—Senior Director, Marketing

By Erica Klinger, Senior Director, Marketing




Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.